Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 73

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 73
---
 Predecessor |       |
|                                     |     |                   For the 
                    period 
      commencing January 1 |       |   |     |              For the 
               period 
 commencing January 1 |       |
|                                     |     |                   through 
                   July 23 |       |   |     |              through 
              July 23 |       |
|                                     |     |                      2024 |       |   |     |                 2024 |       |
|                                     |     |                 Unaudited |       |   |     |            Unaudited |       |
| Operating expenses                  |     |                           |       |   |     |                      |       |
| Research and development expenses   |     |                           | 1,171 |   |     |                      | 1,162 |
| General and administrative expenses |     |                           | 4,396 |   |     |                      |   257 |
| Operating loss                      |     |                           | 5,567 |   |     |                      | 1,419 |
| Financial expense (income), net     |     |                           |  (155 | ) |     |                      |     2 |
| Net loss and comprehensive loss     |     |                           | 5,412 |   |     |                      | 1,421 |

Research and Development Expenses

Successor’s and Predecessor’s research
and development expenses totaled $1,171 thousand for the period commencing January 1, 2024 through July 23, 2024, representing an increase
of $9 thousand, or 0.8%, compared to Predecessor’s $1,162 thousand for the same period. The research and development expenses comprise
mainly from salaries and related expenses, from share based payment expenses and other expenses. The increase was immaterial.

General and Administrative Expenses

Successor’s and Predecessor’s general
and administrative expenses totaled $4,396 thousand for the period commencing January 1, 2024 through July 23, 2024, representing an
increase of $4,139 thousand, or 1,610.5%, compared to Predecessor’s $257 thousand for the same period. The increase was primarily
attributable to Successor’s share-based payment compensation, Successor’s salaries and related expenses and Successor’s
professional services for such period compared to no such expenses in the Predecessor for the same period.

<div align='center'>43</div